Biodexa Pharmaceuticals plc - American Depositary Shares (BDRX)

$1.19 0.05 (4.03%)

15:59 EDT BDRX Stock Quote Delayed 30 Minutes

Why Is Biodexa (BDRX) Up 70% Today?

By Josh Enomoto, InvestorPlace Contributor Apr 26, 2024

Oncology specialist Biodexa inked a compelling licensing deal to treat a serious disease, and BDRX stock popped sharply higher.

Why Is Biodexa Pharmaceuticals (BDRX) Stock Up 106% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 487,464

Day's Range $1.16 - $1.37

52-Week Range $0.67 - $17.60

Dividend & Yield N/A (N/A)

BDRX Stock Predictions, Articles, and Biodexa Pharmaceuticals plc - American Depositary Shares News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Nov 29, 2023

Pre-market stock movers are a good way to start the day as we dive into the biggest news worth checking out on Wednesday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Jul 12, 2023

It's time to start off Wednesday with an overview of all the biggest pre-market stock movers worth watching this morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Jun 27, 2023

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on Tuesday morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jun 23, 2023

It's time for a final dive into the biggest pre-market stock movers this week as we check out what's happening on Friday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Mar 29, 2023

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on!

Why Is Midatech Pharma (BDRX) Stock Up 64% Today?

By William White, InvestorPlace Writer Mar 28, 2023

Midatech Pharma (BDRX) stock is rocketing higher on Tuesday after the pharmaceutical company announced a new research program.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Mar 28, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday!

Biodexa stock slides 7% amid data for two drug studies (NASDAQ:BDRX)

From Seeking Alpha Feb 23, 2024

Shares of Biodexa (BDRX) slid 7% in morning trading Friday after the biotech company reported study results for two of its therapy candidates. Biodexa said an i

Biodexa stock jumps on allowance of U.S. patent covering Tolimidone (NASDAQ:BDRX)

From Seeking Alpha Feb 7, 2024

Biodexa Pharmaceuticals sees a 40% surge in premarket trading as the US Patent Office allows its patent application for Tolimidone's use in treating T1D.

Biodexa Pharmaceuticals down 21%, prices equity offering (NASDAQ:BDRX)

From Seeking Alpha Dec 19, 2023

Clinical stage biopharmaceutical company Biodexa Pharmaceuticals prices underwritten public offering of units, with a closing expected on December 21, 2023.

Biodexa Pharmaceuticals announces ADR ratio change (NASDAQ:BDRX)

From Seeking Alpha Jun 23, 2023

With the aim at regaining compliance with Nasdaq's minimum bid price listing requirement, Biodexa Pharmaceuticals (BDRX) changes its American Depository Receipt/ordinary share ratio...

BDRX receives Nasdaq delisting notice, plans to appeal decision (NASDAQ:BDRX)

From Seeking Alpha Jun 15, 2023

Biodexa Pharmaceuticals (BDRX) said on Thursday that Nasdaq had notified the company of its intent to delist its stock due to BDRX's stock having had a close bid price below $0.10 for...

Biodexa Pharmaceuticals (NASDAQ:BDRX)

From Seeking Alpha Apr 3, 2023

Biodexa Pharmaceuticals (BDRX) issued an additional 10.5M pre-funded warrants, calculated by dividing the aggregate subscription amount by 90% of the average of the daily volume...

ADVERTISEMENT